Please reload

Recent Posts

I'm busy working on my blog posts. Watch this space!

Please reload

Featured Posts

What is behind the last numbers of the Second Quarter Fiscal Year 2018 Results for PALATIN TECHNOLOGIES INC PTN ?

February 14, 2018

 * Last result show more improved and balance at the fundamental sheet .They already  Received $417,500 in December 2017, consisting of an upfront payment of a license agreement with Kwangdong Pharmaceutical Co., Ltd.

("Kwangdong") in November 2017 for exclusive rights to develop and

commercialize bremelanotide in the Republic of Korea.
*Received $4,500,000 in October 2017, consisting of an upfront payment of

$5,000,000 less $500,000 which was withheld in accordance with tax

withholding requirements in China.
*Working closely with AMAG Pharmaceuticals, Inc. ("AMAG"), our licensee

for North America, on completing the tasks and activities necessary to file a New Drug Application ("NDA") with the Food and Drug Administration ("FDA"). With all this positive signs I can easy say this stock might keep improving and show a great potential of growth . My rate for this stock is Strong Hold /Buy rate for the next 20 days with good entry to buy between 0.82 and 0.91 .My price target for the next 20 days is 1.20 $ . this article is my private thought about this stock ,I don’t own any insider positions at this stock ,you are free to buy .hold or sell your position.

 


Share on Facebook
Share on Twitter
Please reload

Follow Us

I'm busy working on my blog posts. Watch this space!

Please reload

Search By Tags
Please reload

Archive
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

© 2023 by Success Consulting. Proudly created with Wix.com.